1 |
NEWMAN D J, CRAGG G M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019[J]. Journal of Natural Products, 2020, 83(3): 770-803.
|
2 |
奚萌宇, 胡逸灵, 顾玉诚, 等. 基因组挖掘指导天然药物分子的发现[J]. 合成生物学, 2024, 5(3):447-473.
|
|
XI Mengyu, HU Yiling, GU Yucheng, et al. Genome mining-directed discovery for natural medicinal products[J]. Synthetic Biology Journal, 2024, 5(3): 447-473.
|
3 |
宋永相, 张秀凤, 李艳芹, 等. 自抗性基因导向的活性天然产物挖掘[J]. 合成生物学, 2024, 5(3):474-491.
|
|
SONG Yongxiang, ZHANG Xiufeng, LI Yanqin, et al. Resistance-gene directed discovery of bioactive natural products[J]. Synthetic Biology Journal, 2024, 5(3): 474-491.
|
4 |
虞旭昶, 吴辉, 李雷. 文库构建与基因簇靶向筛选驱动的微生物天然产物高效发现[J]. 合成生物学, 2024, 5(3):492-506.
|
|
YU Xuchang, WU Hui, LI Lei. Library construction and targeted BGC screening for more efficient discovery of microbial natural products[J]. Synthetic Biology Journal, 2024, 5(3): 492-506.
|
5 |
雷茹, 陶慧, 刘天罡. 基因组深度挖掘驱动微生物萜类化合物高效发现[J]. 合成生物学, 2024, 5(3):507-526.
|
|
LEI Ru, TAO Hui, LIU Tiangang. Deep genome mining boosts the discovery of microbial terpenoids[J]. Synthetic Biology Journal, 2024, 5(3): 507-526.
|
6 |
冯金, 潘海学, 唐功利. 近十年天然产物药物的生物合成研究进展[J]. 合成生物学, 2024, 5(3):408-446.
|
|
FENG Jin, PAN Haixue, TANG Gongli. Research advances in biosynthesis of natural product drugs within the past decade[J]. Synthetic Biology Journal, 2024, 5(3):408-446.
|
7 |
刘晓楠, 李静, 祝晓熙, 等. 紫杉醇生物合成机制研究进展[J]. 合成生物学, 2024, 5(3):527-547.
|
|
LIU Xiaonan, LI Jing, ZHU Xiaoxi, et al. Research advances on paclitaxel biosynthesis[J]. Synthetic Biology Journal, 2024, 5(3): 527-547.
|
8 |
张瑞, 金文铮, 陈依军. 细菌聚酮合酶间的杂合方式及聚酮化合物生物合成逻辑[J]. 合成生物学, 2024, 5(3):548-560.
|
|
ZHANG Rui, JIN Wenzheng, CHEN Yijun. Bacterial inter-PKS hybrids and the biosynthetic algorithm of polyketides[J]. Synthetic Biology Journal, 2024, 5(3): 548-560.
|
9 |
张俊, 金诗雪, 云倩, 等. 聚酮化合物非天然延伸单元的生物合成与结构改造应用[J]. 合成生物学, 2024, 5(3):561-570.
|
|
ZHANG Jun, JIN Shixue, YUN Qian, et al. Biosynthesis of the unnatural extender units with polyketides and their structural modifications for applications in medicines[J]. Synthetic Biology Journal, 2024, 5(3): 561-570.
|
10 |
陈锡玮, 张华然, 邹懿. 真菌源非核糖体肽类药物生物合成及代谢工程[J]. 合成生物学, 2024, 5(3):571-592.
|
|
CHEN Xiwei, ZHANG Huaran, ZOU Yi. Biosynthesis and metabolic engineering of fungal non-ribosomal peptides[J]. Synthetic Biology Journal, 2024, 5(3): 571-592.
|
11 |
施鑫杰, 杜艺岭. 双嵌入家族抗肿瘤非核糖体肽的生物合成研究进展[J]. 合成生物学, 2024, 5(3):593-611.
|
|
SHI Xinjie, DU Yiling. Research advances in the biosynthesis of nonribosomal peptides within the bisintercalator family as anticancer drugs[J]. Synthetic Biology Journal, 2024, 5(3): 593-611.
|
12 |
汤志军, 胡友财, 刘文. 酶促 4+ 2 和 2+ 2 环加成反应: 区域与立体选择性的理解与应用[J]. 合成生物学, 2023, 5(3):401-407.
|
|
TANG Zhijun, HU Youcai, LIU Wen. Enzymatic (4+2)- and (2+2)-cycloaddition reactions: fundamentals and applications of regio- and stereoselectivity[J]. Synthetic Biology Journal, 2024, 5(3): 401-407.
|
13 |
谢皇, 郑义蕾, 苏依婷, 等. 放线菌聚酮类化合物生物合成体系重构研究进展[J]. 合成生物学, 2024, 5(3):612-630.
|
|
XIE Huang, ZHENG Yilei, SU Yiting, et al. An overview on reconstructing the biosynthetic system of actinomycetes for polyketides production[J]. Synthetic Biology Journal, 2024, 5(3): 612-630.
|
14 |
查文龙, 卜兰, 訾佳辰. 中药药效成分群的合成生物学研究进展[J]. 合成生物学, 2024, 5(3):631-657.
|
|
ZHA Wenlong, BU Lan, ZI Jiachen. Advances in synthetic biology for producing potent pharmaceutical ingredients of traditional Chinese medicine[J]. Synthetic Biology Journal, 2024, 5(3): 631-657.
|
15 |
惠真, 唐啸宇. CRISPR/Cas9 编辑系统在微生物天然产物研究中的应用[J]. 合成生物学, 2024, 5(3):658-671.
|
|
HUI Zhen, TANG Xiaoyu. Applications of the CRISPR/Cas9 editing system in the study of microbial natural products [J]. Synthetic Biology Journal, 2024, 5(3):658-671.
|
16 |
陈盈盈, 刘扬, 史俊杰, 等. CRISPR/Cas 基因编辑及其新兴技术在丝状真菌研究中的系统应用[J]. 合成生物学, 2024, 5(3):672-693.
|
|
CHEN Yingying, LIU Yang, SHI Junjie, et al. CRISPR/Cas systems and their applications in gene editing with filamentous fungi[J]. Synthetic Biology Journal, 2024, 5(3): 672-693.
|